Spire Healthcare Group (LON:SPI) Shares Down 16.9% – Here’s Why

Shares of Spire Healthcare Group plc (LON:SPI) fell 16.9% during mid-day trading on Wednesday . The stock traded as low as GBX 185 and last traded at GBX 185.80. 8,659,000 shares were traded during mid-day trading, an increase of 493% from the average session volume of 1,461,109 shares. The stock had previously closed at GBX 223.50.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. dropped their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating for the company in a report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, Spire Healthcare Group currently has an average rating of “Buy” and an average target price of GBX 294.33.

Spire Healthcare Group Trading Down 16.9%

The company’s 50 day moving average price is GBX 234.27 and its 200 day moving average price is GBX 222.02. The firm has a market cap of £747.61 million, a PE ratio of 40.39, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.